Clinical Trial Update: Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating long-term oral aripiprazole in pediatric Tourette's Disorder was terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Tourette's Disorder (TD) | Phase 4 | Status: TERMINATED | Results posted: 2021-01-22